Delivery Order SPE2DB22D2206-SPE2DB25FGA08
Award Date
3/10/25
Potential Completion Date
3/11/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFB36, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,786.07, is a firm fixed-price delivery order for the pharmaceutical product BRIVIACT 100 MG TABLET 60S. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
This federal contract award SPE2DB22D2206|SPE2DB24FHS98, valued at $3,595.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a completion date of June 13, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,379.13 Firm Fixed Price Delivery Order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.86 firm-fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FANN8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $14,718.00 Firm Fixed Price Delivery Order contract is for the supply of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $3,405.36, is for the delivery of BRIVIACT 25 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 31, 2024 and a contract type of Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,764.22 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,644.95 firm fixed-price delivery order is for the supply of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award SPE2DB20D3505 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,465.04 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,954.55 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...